Locoregional IL-2 immunotherapy of bladder cancer

Immunopharmacol Immunotoxicol. 1997 Feb;19(1):1-13. doi: 10.3109/08923979709038530.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Intravesical
  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Drug Therapy, Combination
  • Humans
  • Immunotherapy
  • Infusions, Intra-Arterial
  • Injections, Intralesional
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / therapeutic use*
  • Urinary Bladder Neoplasms / immunology
  • Urinary Bladder Neoplasms / therapy*

Substances

  • Antineoplastic Agents
  • Interleukin-2